In vivo effect of copper status on cisplatin-induced nephrotoxicity

Biometals. 2016 Oct;29(5):841-9. doi: 10.1007/s10534-016-9955-z. Epub 2016 Aug 1.

Abstract

Cisplatin is a widely used antitumor agent; however, tumor resistance and severe side effects limit its use. It is well accepted that cisplatin toxicity can be modulated in vitro in cell cultures by copper salts. In the present work, mice with different blood serum copper status were treated with a single intraperitoneal cisplatin injection at a dose of 5 mg/kg, monitored for 3 days in metabolic cages and analyzed for renal function. Both copper-deficient and copper-overloaded mice displayed more severe early proteinuria and retarded platinum excretion than control mice. The effects of copper status on cisplatin-induced nephrotoxicity are discussed.

Keywords: Cisplatin; Murine model of copper status; Nephrotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / toxicity*
  • Cisplatin / administration & dosage
  • Cisplatin / toxicity*
  • Copper Sulfate / administration & dosage
  • Copper Sulfate / blood*
  • Copper Sulfate / toxicity
  • Injections, Intraperitoneal
  • Kidney / drug effects*
  • Kidney / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Platinum / analysis
  • Platinum / pharmacokinetics
  • Proteinuria / chemically induced*
  • Proteinuria / metabolism
  • Tissue Distribution

Substances

  • Antineoplastic Agents
  • Platinum
  • Copper Sulfate
  • Cisplatin